Federal Register of Legislation - Australian Government

Primary content

SR 1981 No. 52 Regulations as made
These Regulations amend the National Health (Pharmaceutical Benefits) Regulations.
Administered by: Health
General Comments: This instrument was backcaptured in accordance with Section 36 of the Legislative Instruments Act 2003
Registered 01 Jan 2005
Tabling HistoryDate
Tabled HR01-Apr-1981
Tabled Senate01-Apr-1981
Gazetted 31 Mar 1981
Date of repeal 19 Mar 2014
Repealed by Health (Spent and Redundant Instruments) Repeal Regulation 2014

Statutory Rules 1981 No. 521

_______________

National Health (Pharmaceutical Benefits)
Regulations
2 (Amendment)

            WHEREAS it is provided by sub-section 101 (4) of the National Health Act 1953 that a drug or medicinal preparation that was not a pharmaceutical benefit under that Act immediately before the commencement of that sub-section shall not be prescribed as a pharmaceutical benefit in accordance with section 85 of that Act unless the Pharmaceutical Benefits Advisory Committee has recommended to the Minister that it be so prescribed:

            AND WHEREAS the Pharmaceutical Benefits Advisory Committee has recommended to the Minister that each drug and medicinal preparation the name of which is specified in Schedule 3 to the following Regulations be prescribed as a pharmaceutical benefit in accordance with section 85 of the National Health Act 1953:

            AND WHEREAS it is desirable, amongst other things, to prescribe, for the purpose of section 85 of the National Health Act 1953, each drug and medicinal preparation so recommended by the Pharmaceutical Benefits Advisory Committee:

            NOW THEREFORE I, the Governor-General of the Commonwealth of Australia, acting with the advice of the Federal Executive Council, hereby make the following Regulations under the National Health Act 1953.

          Dated 25 March 1981.

                                                                                                                           ZELMAN COWEN

                                                                                                                           Governor-General

          By His Excellency’s Command,

 

MICHAEL MACKELLAR

Minister of State for Health

_______________

                Commencement

          1.   These Regulations shall come into operation on 1 April 1981.

                Pharmaceutical benefits that may be prescribed only for specified persons, diseases, &c.

          2.   Regulation 14 of the National Health (Pharmaceutical Benefits) Regulations is amended—

                (a)    by omitting from paragraph (d) of sub-regulation (2) “writing of a prescription for the supply of the pharmaceutical benefit has been made by the medical practitioner intending to write the prescription” and substituting “supply of the pharmaceutical benefit has been made by a medical practitioner”; and

               (b)    by omitting sub-regulation (3) and substituting the following sub-regulation:

                       “(3)    Where a medical practitioner makes an application under paragraph (2) (d) and the Permanent Head approves the application, the Permanent Head shall record his approval on a numbered authority and—

                                    (a)     where, in the approval, the Permanent Head requires the medical practitioner to vary the prescription for the supply of the pharmaceutical benefit-return the approval to the medical practitioner; or

                                    (b)     in any other case-forward the approval to the person to whom the pharmaceutical benefit is to be supplied.”.

                Supply of pharmaceutical benefits on prescriptions

          3.   Regulation 21 of the National Health (Pharmaceutical Benefits) Regulations is amended by omitting from paragraph (e) of sub-regulation (1) “accompanied by a numbered” and substituting “written upon an”.

                Repeat authorizations

          4.   Regulation 26 of the National Health (Pharmaceutical Benefits) Regulations is amended by omitting from paragraph (e) of sub-regulation (1) “accompanied by a numbered” and substituting “written upon an”.

                Schedule 1

          5.   Schedule 1 to the National Health (Pharmaceutical Benefits) Regulations is amended as set out in Schedule 1.

                Schedule 2

          6.   Schedule 2 to the National Health (Pharmaceutical Benefits) Regulations is amended as set out in Schedule 2.

                Schedule 3

          7.   Schedule 3 to the National Health (Pharmaceutical Benefits) Regulations is amended as set out in Schedule 3.

                Schedule 4

          8.   Schedule 4 to the National Health (Pharmaceutical Benefits) Regulations is amended as set out in Schedule 4.

                Schedule 5

          9.   Schedule 5 to the National Health (Pharmaceutical Benefits) Regulations is amended as set out in Schedule 5.

                                                   SCHEDULE 1                                  Regulation 5

AMENDMENTS OF SCHEDULE 1 TO THE NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS

       1.       After item 54 insert the following item:

“54A           Benzalkonium Chloride Solution”.

       2.       After item 64 insert the following item:

“64A           Borax”.

       3.       After item 65 insert the following item:

“65A           Brilliant Green”.

       4.       After item 92 insert the following item:

“92A           Cardamom Tincture, Compound”.

       5.       After item 136 insert the following item:

“136A         Cocaine”.

       6.       After item 235 insert the following item:

“235A         Disodium Edetate”.

       7.       Omit item 244.

       8.       After item 252 insert the following item:

“252A         Ephedrine Hydrochloride Tablets”.

       9.       After item 282 insert the following item:

“282A         Ferric Ammonium Citrate”.

     10.       Omit item 305.

     11.       After item 309 insert the following items:

“309A           Ginger Tincture, Strong

309B           Ginger Tincture, Weak”.

     12.       After item 380 insert the following item:

“380A         Isoprenaline Hydrochloride Injection”.

     13.       After item 449 insert the following item:

“449A         Methoin Tablets”.

     14.       After item 496 insert the following item:

“496A         Noradrenaline Acid Tartrate”.

     15.       After item 605 insert the following item:

“605A         Potassium Hydroxide Solution”.

     16.       After item 658 insert the following item:

“658A         Reserpine”.

     17.       After item 659 insert the following items:

“659A           Rhubarb

659B           Rhubarb Tincture, Compound”.

     18.       After item 676 insert the following item:

“676A         Smallpox Vaccine”.

     19.       After item 679 insert the following item:

“679A         Sodium Acid Phosphate”.

     20.       After item 718 insert the following item:

“718A         Sucrose”.

     21.       After item 726 insert the following item:

“726A         Sulphamethoxydiazine Tablets”.

     22.       After item 727 insert the following item:

“727A         Sulphamethoxypyridazine Tablets”.

     23.       After item 737 insert the following items:

“737A           Tannic Acid

737B           Tar”.

                                           SCHEDULE 2                            Regulation 6

AMENDMENTS OF SCHEDULE 2 TO THE NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS

       1.       After item 7 insert the following items:

“7A

Aluminium Hydroxide Gel B.P.

Magnesium Hydroxide with Aluminium

     Hydroxide Gel, B.P.

 

 

Magnesium Hydroxide with Oxethazaine

     and Aluminium Hydroxide Gel, B.P.

 

 

Light Kaolin, B.P. or Light Kaolin (Natural) B.P.

      with Aluminium Hydroxide Gel

7B

Aluminium Hydroxide Gel Dried B.P.

Magnesium Hydroxide with Aluminium Hydroxide

     Gel Dried B.P.

Magnesium Trisilicate with Magnesium Hydroxide

     and Aluminium Hydroxide Gel Dried, B.P.

7C

Aluminium Hydroxide and Magnesium Carbonate Co-dried Gel

—”.

       2.       After item 9 insert the following item:

“9A

Aminacrine Hydrochloride, B.P. 1968

—”.

       3.       Omit item 13.

       4.       Omit item 19, substitute the following item:

“19

Atropine Methonitrate

—”.

       5.       After item 40 insert the following item:

“40A

Camphor Compound Linctus

—”.

       6.       Omit item 44.

       7.       After item 57 insert the following item:

“57A

Codeine, Linctus, A.P.F.

—”.

       8.       After item 84 insert the following item:

“84A

Epicillin

Purified Water, B.P. with Epicillin”.

       9.       After item 106 insert the following item:

“106A

Gelatin

Sodium Carboxymethyl cellulose with Pectin and Gelatin”

     10.       After item 110 insert the following items:

“110A

Glycerophosphate Compound Syrup A.P.F. 1964

110B

Glyceryl Trinitrate

—”

     11.       Omit item 123.

     12.       After item 139 insert the following item:

“39A

Morphine Sulphate

Atropine Sulphate with Morphine Sulphate

Tacrine Hydrochloride with Morphine Sulphate”

     13.       Omit item 147.

     14.       Omit item 159, substitute the following item:

“59

Pectin

Gelatin with Sodium Carboxymethylcellulose and Pectin

Kaolin Light B.P. or Light Kaolin (Natural) B.P. with Pectin”.

     15.       After item 182 insert the following item:

“82A

Senega and Ammonia Mixture, A. P.F.

—”

                                                   SCHEDULE 3                                  Regulation 7

AMENDMENTS OF SCHEDULE 3 TO THE NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS

       1.       Omit item 3.

       2.       After item 13 insert the following item:

“13A

Aluminium Hydroxide and Magnesium Carbonate Co-dried Gel”.

       3.       Omit item 17, substitute the following items:

“17

Amaranth Solution, A.P.F. 1964

17A

Amaranth Solution, A.P.F.

17B

Amaranth Solution Compound, A.P.F.”.

       4.       Omit item 33.

       5.       Omit item 51.

       6.       After item 56 insert the following item:

“56A

Calcitriol”.

       7.       Omit item 60, substitute the following item:

“60

Camphor Compound Linctus, A.P.F.”.

       8.       Omit item 62.

       9.       Omit item 63.

     10.       Omit item 66.

     11.       After item 85 insert the following item:

“85A

Codeine Linctus, A.P.F.”.

     12.       Omit item 87.

     13.       Omit item 130.

     14.       Omit item 131.

     15.       After item 137 insert the following item:

“137A

Glyceryl Trinitrate”.

     16.       Omit item 147.

     17.       Omit item 178.

     18.       Omit item 179, substitute the following item:

“179

Lemon Spirit, A.P.F.”.

     19.       Omit item 192.

     20.       After item 198, insert the following item:

“198A

Metolazone”.

     21.       Omit item 202.

     22.       Omit item 232.

     23.       After item 269, insert the following item:

“269A

Senega and Ammonia Mixture, A.P.F.”.

     24.       Omit item 272.

     25.       After item 273 insert the following item:

“273A

Soap Liniment B.P.C.”.

     26.       Omit item 299, substitute the following item:

“299

Tamoxifen Citrate”.

     27.       After item 304 insert the following item:

“304A

Tetrabenazine”.

     28.       After item 309 insert the following item:

“309A

Thymol Mouth-Wash Compound, A.P.F.”.

                                                   SCHEDULE 4                                  Regulation 8

AMENDMENTS OF SCHEDULE 4 TO THE NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS

       1.       After item 3 insert the following item:

“3A

Borax, B.P.”.

       2.       Omit item 11.

       3.       Omit item 13.

       4.       Omit item 21.

                                                   SCHEDULE 5                                  Regulation 9

AMENDMENTS OF SCHEDULE 5 TO THE NATIONAL HEALTH (PHARMACEUTICAL BENEFITS) REGULATIONS

       1.       After item 17 insert the following item:

“17A

Calcitriol

With the written authority of the Permanent Head—

Use in hospitals for hypocalcaemia due to renal disease”.

       2.       Omit item 60 substitute the following item:

“60

Dipyridamole

With the written authority of the Permanent Head—

Supplementing anticoagulants in-Biopsy proven glomerulo-nephritis

Mesangiocapillary renal disease

Renal allograft

Patients with cardiac prosthesis”.

       3.       After item 61 insert the following item:

“61A

Dydrogesterone Tablets

With the written authority of the Permanent Head—

Endometriosis, proven by visual means”.

       4.       Omit item 79 substitute the following item:

“79

  (1)  Idoxuridine Eye Drops

  (2)  Idoxuridine Eye Ointment

Eye infections caused by Herpes Simplex Virus”.

       5.       After item 129 insert the following item:

“129A

Pindolol, Tablet 15 mg

Hypertension where there is an inadequate response to not less than 15 mg of pindolol daily

Frequent disabling angina without evidence of cardiac failure where there is an inadequate response to not less than 15 mg of pindolol daily”.

       6.       Omit item 147 substitute the following items:

“147

Sodium Cromoglycate B.P.

Capsule 10 mg

With the written authority of the Permanent Head—
Allergic rhinitis not responding to other treatment

147A

Sodium Cromoglycate B.P.

Eye Drops

With the written authority of the Permanent Head—
Vernal kerato-conjunctivitis demonstrated by eosinophils in conjunctival scrapings”.

       7.       After item 155 insert the following item:

“155A

Tamoxifen Citrate

With the written authority of the Permanent Head—

Treatment of post-menopausal metastatic breast cancer”.

       8.       After item 157 insert the following item:

“157A

Tetrabenazine

With the written authority of the Permanent Head—

Chorea not adequately controlled by other drug therapy”.

       9.       Omit item 173, substitute the following item:

“173

Vidarabine

Eye infections caused by Herpes Simplex Virus where idoxuridine has proved ineffective”.

 

NOTES

1.       Notified in the Commonwealth of Australia Gazette on 31 March 1981.

2.       Statutory Rules 1960 No. 17 as amended by 1960 Nos. 90 and 102; 1961 Nos. 59 and 137; 1962 Nos. 34, 101 and 114; 1963 Nos. 34, 69 and 107; 1964 Nos. 12, 57 and 135; 1965 Nos. 51, 151 and 152; 1966 Nos. 80 and 144; 1967 Nos. 67, 116 and 158; 1968 Nos. 44, 76, 88 and 146; 1969 Nos. 44, 107 and 185; 1970 Nos. 39, 94, 119 and 186; 1971 Nos. 44, 101, 136 and 154; 1972 Nos. 32, 121 and 205; 1973 Nos. 15, 57, 139 and 229; 1974 Nos. 37, 126 and 222; 1975 Nos. 50, 148 and 209; 1976 Nos. 84, 150, 195 and 255; 1977 Nos. 39, 125 and 221; 1978 Nos. 47, 142, 153 and 245; 1979 Nos. 51, 55, 144 and 250; 1980 Nos. 69, 213 and 338.